False multiple coin lesions in prostatic cancer under hormone therapy
Kattan, J.; Court, B.; Culine, S.; Droz, J.P.
Presse Medicale 22(23): 1104
1993
ISSN/ISBN: 0755-4982 PMID: 8415464 Document Number: 417985
Document emailed within 1 workday
Related Documents
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R. 1980: Hormone therapy in prostatic cancer Acta Urologica Belgica 48(1): 98-105Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356
Machida, T.; Ikemoto, I. 1987: Hormone therapy of male genital cancer (prostatic cancer) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2845-2852
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Klosterhalfen, H. 1977: Hormone therapy of prostatic carcinoma Deutsche Medizinische Wochenschrift 102(25): 947
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366
Haapiainen, R.; Rannikko, S.; Alfthan, O.; Adlercreutz, H. 1988: Pretreatment hormone levels in prostatic cancer Scandinavian Journal of Urology and Nephrology. Supplementum 110: 137-143
Stoter, G.; Jones, W.G. 1988: Chemotherapy of hormone refractory prostatic cancer Progress in Clinical and Biological Research 260: 123-125
Wemeau, L.; Mazeman, E.; Blanckaert, J.; Delhay, J. 1972: Results of hormone treatment of prostatic cancer. 168 cases Acta Urologica Belgica 40(1): 101-105
Ebert, T.; Bendhack, M.L. 1997: Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy Der Urologe. Ausg. a 36(6): 570-577
Davia, J.E. 1979: Avoiding thoracotomy in vascular coin lesions of the lung Medical Times 107(8): 87-92
Ansorg, P.; Assmann, H. 1970: Indications for surgery in isolated coin lesions of the lung Zentralblatt für Chirurgie 95(12): 362-367
Davia, J.E. 1979: Avoiding thoracotomy in vascular coin lesions of the lung Medical Times 107(8): 87-92
Burk, K.; Schultze-Seemann, W.; Jonas, D.; Rodeck, G. 1989: Weekly epirubicin in patients with hormone refractory prostatic cancer--a two-year follow-up Progress in Clinical and Biological Research 303: 277-285
Aaserud, A.; Thomle, S.; Fosså, S.D. 1993: Treatment of threatened spinal cord lesions in patients with prostatic cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(17): 2141
Eichenberger, T.; Trachtenberg, J.; Chronis, P.; Keating, A. 1989: Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(6): 363-366
Matzkin, H.; Greenstein, A.; Kaver, I.; Braf, Z. 1989: Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience Israel Journal of Medical Sciences 25(7): 388-392
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Vieillefond, A.; Berger, N.; Dauge-Geffroy, M.C.; Saint Andre, J.P. 1993: Prostatic adenosis and dysplasia. what is their definition... and their significance? Are there "precancerous" lesions in prostatic pathology? Annales de Pathologie 13(2): 85-87
Gez, E.; Ben-Yosef, R.; Libson, E.; Biran, S. 1987: The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma Harefuah 112(5): 239-241